Abstract
Adenovirus-based vectors are widely developed for potential utilization as vectors in vaccine and gene therapy strategies. We focused on developing a helper-dependent adenoviral (HD-Ad) vector for the potential use of CELO, a member of the Aviadenovirus genus, in avian species vaccination. Our aim was to localize sequences which could play an essential role in CELO genome encapsidation and, when deleted, was unable to produce viruses to develop a helper CELO virus. A panel of 6 mutants with deletions between nt 80 and 350 of the CELO genome was constructed and characterized for its ability to produce viable virus. To develop a helper-dependent adenoviral vector derived from CELO, a helper virus was developed by inserting loxP sequences around the region containing the identified putative packaging sequences. A LMH (Leghorn Male Hepatocarcinoma) cell line expressing Cre recombinase was developed to allow the excision of this region. We demonstrated that the region from nt 200 to 250 was important and the region from nt 250 to 300 at the left end of the CELO genome was essential for virus encapsidation. We also showed that the loxP-flanked region was efficiently removed in a Cre expressing cell line to produce a candidate helper virus.
Similar content being viewed by others
References
C.M. Fauquet, M.A. Mayo, J. Maniloff, U. Desselberger, L.A. Ball, Virus taxonomy. Classification and Nomenclature of Viruses. Eight Report of the International Committee on the Taxonomy of Viruses (Elsevier Academic Press, 2005)
D.S. Bangari, S.K. Mittal, Vaccine 24, 849–862 (2006). doi:https://doi.org/10.1016/j.vaccine.2005.08.101
N. Tatsis, H.C. Ertl, Mol. Ther. 10, 616–629 (2004). doi:https://doi.org/10.1016/j.ymthe.2004.07.013
W.C. Russell, J. Gen. Virol. 81, 2573–2604 (2000)
R. Alba, A. Bosch, M. Chillon. Gene Ther. 12(Suppl 1), S18–S27 (2005). doi:https://doi.org/10.1038/sj.gt.3302612
M.A. Morsy, M. Gu, S. Motzel, J. Zhao, J. Lin, Q. Su et al., Proc. Natl. Acad. Sci. USA 95, 7866–7871 (1998). doi:https://doi.org/10.1073/pnas.95.14.7866
M. Havenga, R. Vogels, D. Zuijdgeest, K. Radosevic, S. Mueller, M. Sieuwerts et al., J. Gen. Virol. 87, 2135–2143 (2006). doi:https://doi.org/10.1099/vir.0.81956-0
P.S. Reddy, S. Ganesh, M.P. Limbach, T. Brann, A. Pinkstaff, M. Kaloss et al., Virology 311, 384–393 (2003). doi:https://doi.org/10.1016/S0042-6822(03)00161-2
A.A. Lemckert, J. Grimbergen, S. Smits, E. Hartkoorn, L. Holterman, B. Berkhout et al., J. Gen. Virol. 87, 2891–2899 (2006). doi:https://doi.org/10.1099/vir.0.82079-0
L. Holterman, R. Vogels, R. van der Vlugt, M. Sieuwerts, J. Grimbergen, J. Kaspers et al., J. Virol. 78, 13207–13215 (2004). doi:https://doi.org/10.1128/JVI.78.23.13207-13215.2004
E.J. Kremer, S. Boutin, M. Chillon, O. Danos, J. Virol. 74, 505–512 (2000)
A. Keriel, C. Rene, C. Galer, J. Zabner, E.J. Kremer, J. Virol. 80, 1487–1496 (2006). doi:https://doi.org/10.1128/JVI.80.3.1487-1496.2006
S. Roy, Y. Zhi, G.P. Kobinger, J. Figueredo, R. Calcedo, J.R. Miller et al., J. Gen. Virol. 87, 2477–2485 (2006). doi:https://doi.org/10.1099/vir.0.81989-0
P.S. Reddy, N. Idamakanti, Y. Chen, T. Whale, L.A. Babiuk, M. Mehtali et al., J. Virol. 73, 9137–9144 (1999)
P.S. Reddy, N. Idamakanti, L.A. Babiuk, M. Mehtali, S.K. Tikoo, J. Gen. Virol. 80(Pt 11), 2909–2916 (1999)
J.S. Rothel, D.B. Boyle, G.W. Both, A.D. Pye, J.G. Waterkeyn, P.R. Wood et al., Parasite Immunol. 19:221–227. (1997). doi:https://doi.org/10.1046/j.1365-3024.1997.d01-200.x
A. Francois, C. Chevalier, B. Delmas, N. Eterradossi, D. Toquin, G. Rivallan et al., Vaccine 22, 2351–2360 (2004). doi:https://doi.org/10.1016/j.vaccine.2003.10.039
S.F. Farina, G.P. Gao, Z.Q. Xiang, J.J. Rux, R.M. Burnett, M.R. Alvira et al., J. Virol. 75, 11603–11613 (2001). doi:https://doi.org/10.1128/JVI.75.23.11603-11613.2001
S. Chiocca, R. Kurzbauer, G. Schaffner, A. Baker, V. Mautner, M. Cotten, J. Virol. 70, 2939–2949 (1996)
S. Washietl, F. Eisenhaber, BMC Bioinformatics 4, 55 (2003). doi:https://doi.org/10.1186/1471-2105-4-55
V. Payet, C. Arnauld, J.P. Picault, A. Jestin, P. Langlois, J. Virol. 72, 9278–9285 (1998)
A. Francois, N. Eterradossi, B. Delmas, V. Payet, P. Langlois, J. Virol. 75, 5288–5301 (2001). doi:https://doi.org/10.1128/JVI.75.11.5288-5301.2001
R.J. Parks, L. Chen, M. Anton, U. Sankar, M.A. Rudnicki, F.L. Graham, Proc. Natl. Acad. Sci. USA 93, 13565–13570 (1996). doi:https://doi.org/10.1073/pnas.93.24.13565
M. Grable, P. Hearing, J. Virol. 64, 2047–2056 (1990)
M. Grable, P. Hearing, J. Virol. 66, 723–731 (1992)
S.I. Schmid, P. Hearing, J. Virol. 71, 3375–3384 (1997)
P. Hearing, R.J. Samulski, W.L. Wishart, T. Shenk, J. Virol. 61, 2555–2558 (1987)
C. Soudais, S. Boutin, S.S. Hong, M. Chillon, O. Danos, J.M. Bergelson et al., J. Virol. 74, 10639–10649 (2000). doi:https://doi.org/10.1128/JVI.74.22.10639-10649.2000
L. Xing, S.K. Tikoo, Virology 314, 650–661 (2003). doi:https://doi.org/10.1016/S0042-6822(03)00493-8
C. Soudais, S. Boutin, E.J. Kremer, Mol. Ther. 3, 631–640 (2001). doi:https://doi.org/10.1006/mthe.2001.0263
L. Xing, S.K. Tikoo, Virus Res. 104, 207–214 (2004). doi:https://doi.org/10.1016/j.virusres.2004.04.007
L. Xing, S.K. Tikoo, Virus Res. (2007)
L. Xing, L. Zhang, J. Van Kessel, S.K. Tikoo, J. Gen. Virol. 84, 2947–2956 (2003). doi:https://doi.org/10.1099/vir.0.19418-0
W. Zhang, M.J. Imperiale, J. Virol. 74, 2687–2693 (2000). doi:https://doi.org/10.1128/JVI.74.6.2687-2693.2000
W. Zhang, J.A. Low, J.B. Christensen, M.J. Imperiale, J. Virol. 75, 10446–10454 (2001). doi:https://doi.org/10.1128/JVI.75.21.10446-10454.2001
K.E. Gustin, M.J. Imperiale, J. Virol. 72, 7860–7870 (1998)
K.E. Gustin, P. Lutz, M.J. Imperiale, J. Virol. 70, 6463–6467 (1996)
P. Ostapchuk, J. Yang, E. Auffarth, P. Hearing, J. Virol. 79, 2831–2838 (2005). doi:https://doi.org/10.1128/JVI.79.5.2831-2838.2005
P. Perez-Romero, K.E. Gustin, M.J. Imperiale, J. Virol. 80, 1965–1971 (2006). doi:https://doi.org/10.1128/JVI.80.4.1965-1971.2006
P. Ostapchuk, M.E. Anderson, S. Chandrasekhar, P. Hearing, J. Virol. 80, 6973–6981 (2006). doi:https://doi.org/10.1128/JVI.00123-06
S.G. Ewing, S.A. Byrd, J.B. Christensen, R.E. Tyler, M.J. Imperiale, J. Virol. (2007)
F. Le Goff, I. Mederle-Mangeot, A. Jestin, P. Langlois, J. Gen. Virol. 86, 2019–2027 (2005). doi:https://doi.org/10.1099/vir.0.80879-0
J.M. Thomson, W.A. Parrott. Biotechniques 24, 922–924, 926, 928 (1998)
S.I. Schmid, P. Hearing, J. Virol. 72, 6339–6347 (1998)
Y. Maeda, E. Kimura, Y. Uchida, Y. Nishida, S. Yamashita, T. Arima et al., Virology 309, 330–338 (2003). doi:https://doi.org/10.1016/S0042-6822(02)00137-X
P. Ng, R.J. Parks, F.L. Graham, Methods Mol. Med. 69, 371–388 (2002)
P.S. Reddy, K. Sakhuja, S. Ganesh, L. Yang, D. Kayda, T. Brann et al., Mol. Ther. 5, 63–73 (2002). doi:https://doi.org/10.1006/mthe.2001.0510
M. Candolfi, J.F. Curtin, W.D. Xiong, K.M. Kroeger, C. Liu, A. Rentsendorj, H. Agadjanian, L. Medina-Kauwe, D. Palmer, P. Ng, P.R. Lowenstein, M.G. Castro, Mol. Ther. (2006)
P. Ng, C. Beauchamp, C. Evelegh, R. Parks, F.L. Graham, Mol. Ther. 3, 809–815 (2001). doi:https://doi.org/10.1006/mthe.2001.0323
P. Umana, C.A. Gerdes, D. Stone, J.R. Davis, D. Ward, M.G. Castro et al., Nat. Biotechnol. 19, 582–585 (2001). doi:https://doi.org/10.1038/89349
R. Alba, P. Hearing, A. Bosch, M. Chillon, Virology (2007)
Acknowledgements
We would like to thank A. Jestin for the critical reading and correcting of the manuscript. We also thank our colleagues C. Bernard, and B. Grasland for the critical reading of the manuscript and N. Franck, D. Dory and Y. Blanchard for their helpful advice and discussions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barra, C., Langlois, P. First step in characterization of cis-acting sequences involved in fowl adenovirus 1 (CELO) packaging and its effect on the development of a helper-dependent vector strategy. Virus Genes 38, 46–55 (2009). https://doi.org/10.1007/s11262-008-0281-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11262-008-0281-6